Interestingly, miR-M3-5p, another Meq-clustered miRNA, was also demonstrated to contribute to MD oncogenesis by targeting SMAD2, an important component of the TGF-β signaling pathway (Xu et al., 2011). This evidence concerns the gene SMAD2 and Menkes disease.